Investor Relations

Balance Sheet

Condensed Consolidated Balance Sheets - USD ($)
Mar. 31, 2026
Dec. 31, 2025
Condensed Consolidated Balance Sheets  
Statement [Line Items]  
ASSETS  
Current assets:  
Cash and cash equivalents$ 293,794$ 279,525
Inventory, net$ 863,469$ 901,449
Insurance proceeds receivable$ 10,286,000 
Prepaids and other current assets$ 282,559$ 57,850
Note receivable from related party $ 342,974
[Assets, Current]$ 11,725,822$ 1,581,798
Intangible assets - Variable Interest Entities$ 15,433,536$ 15,433,536
Investment in unconsolidated entity$ 2,931,360$ 2,824,126
[Assets]$ 30,090,718$ 19,839,460
LIABILITIES AND STOCKHOLDERS' DEFICIT  
Current liabilities:  
Accounts payable and other accrued expenses$ 5,546,551$ 5,061,330
Accrued interest$ 8,592,548$ 8,187,791
Accrued litigation settlement$ 10,286,000 
Undistributed revenues and royalties$ 1,637,251$ 1,637,251
Due to related parties$ 1,338,330$ 1,338,330
Current portion of long-term debt - net of debt discount$ 45,541,300$ 1,202,956
[Liabilities, Current]$ 72,941,980$ 17,427,658
Long-term debt - net of current portion and debt discount$ 152,715$ 43,698,407
Contingent obligations$ 1,435,757$ 1,435,757
Asset retirement obligation$ 646,360$ 646,360
[Liabilities]$ 75,176,812$ 63,208,182
Commitments and contingencies (Note 11)  
STOCKHOLDERS' DEFICIT  
Preferred stock, value$ 28.00$ 28.00
Common stock, $0.001 par value, 500,000,000 shares authorized, 281,686,525 shares issued and outstanding as of March 31, 2026 and December 31, 2025$ 281,687$ 281,687
Additional paid-in capital$ 162,845,423$ 162,845,423
Accumulated deficit$ (214,578,297)$ (212,901,381)
[Equity, Attributable to Parent]$ (51,451,154)$ (49,774,238)
Non-controlling interest$ 6,365,060$ 6,405,516
[Liabilities and Equity]$ 30,090,718$ 19,839,460
Email Alerts
Contacts
RSS News Feed
crossmenuchevron-downchevron-left